Back
ESC Premium Access

Contributions of small dense LDL and oxidized LDL on the formation of neoatherosclerosis in patients under statin treatment

Session: Basic science e-posters
Topic: Lipids, Metabolism
Speaker: Doctor R. Sakai (Tokyo, JP)
Event: ESC Congress 2021 - The Digital Experience

Presentation

0

About the speaker

Doctor Rikuo Sakai

Showa University Hospital, Tokyo (Japan)
0 follower

202 more presentations in this session

Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress

Speaker: Doctor T. Yamamoto (Tokyo, JP)

Access
Abstract
Slides
0
Thumbnail

MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes

Speaker: Doctor C. Lo (Taichung, TW)

Access
Abstract
Slides
0
Thumbnail

Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense

Speaker: Professor I. Andreadou (Athens, GR)

Access
Abstract
Slides
0
Thumbnail

Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration

Speaker: Associate Professor G. Rigatelli (Rovigo, IT)

Access
Abstract
Slides
0
Thumbnail

Melatonin receptor blockade slows ventricular conduction by IK1 downregulation

Speaker: Doctor M. Gonotkov (Syktyvkar, RU)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Basic science e-posters

Speakers: Doctor R. Sakai, Doctor T. Yamamoto, Doctor C. Lo, Professor I. Andreadou, Associate Professor G. Rigatelli...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Cardiac arrhythmias: from basic research to clinical application.

29 August 2021

ESC Premium Access

Colchicine in Patients Hospitalized with COVID-19

29 August 2021

ESC Premium Access

Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials

27 August 2021

This platform is supported by

logo Novo Nordisk